Background:Most women are diagnosed with breast cancer (BC) when they are still at the appropriate age for employment. The increasing survival rates of patients with BC call for more attention to their ability to return to work.Objectives:The aim of this study was to identify factors related to the return to work in Iranian women underwent BC treatment.Patients and Methods:A total of 175 women with BC, who met the inclusion criteria, were enrolled in this cross-sectional study. The subjects were recruited from four hospitals affiliated to Mashhad university of medical sciences. These hospitals are oncology referral centers in eastern Iran. All records of employed women with BC were studied in four hospitals of Mashhad city, Iran, during 2000 - 2010. The researchers designed a questionnaire, which consisted of questions regarding social/demographic, health/disease, and work characteristics. The questionnaires were completed through interviews. Data were analyzed using SPSS software, version 11.5.Results:The mean age of the patients at the time of interview was 44.3 ± 6.72 years. Mean age of “Return- to-work” group was 42.71 and “No return-to-work” group was 51.06. Most women (80%) were married. At the time of the interview, 80% had returned to work after a BC diagnosis. Older patients (OR = 0.796; 95% CI, 0.625 - 0.907, P = 0.002), and those with a great deal of work experience (OR = 0.861; 95% CI, 0.752 - 0.986, P = 0.030) were less likely to return to work. Also, women who had no pain or surgery scar (OR = 23.03; 95% CI, 4.53 - 117.02, P < 0.001) as well as those who had no lymphedema after the BC treatment were more likely to return to work (OR = 22.373; 95% CI, 4.04 - 23.892, P < 0.001).Conclusions:The results of this study show the factors related to the return-to-work after BC treatment in working women in Mashhad city, Iran. These predictors should be taken into account in order to improve the patient’s life quality.
Introduction: Dry mouth has been reported as a symptom of COVID-19. In this study, xerostomia (dry mouth) was reported in patients with COVID-19. Materials & methods: Dry mouth was assessed in hospitalized patients with COVID-19 daily until all of the dry mouth symptoms resolved. Results: Dry mouth appeared in 60% of cases 3–4 days before as prodromal symptom and in others, simultaneously or 1–2 days after the onset of other symptoms. In most cases, with starting the treatment, dry mouth gradually disappeared. Conclusion: Xerostomia in COVID-19 could occur before the common symptoms. Therefore, it could be hypothesized that it could be used for early diagnosis, quarantine and treatment. As a result, disease transmission might be prevented and the best treatment outcomes could be achieved.
Background:Maternal health status might have an important effect on breastfeeding, growth, and general health of the infants.Objectives:This study was conducted to assess the association between maternal mental health and breastfeeding status of mothers in Kashan province.Patients and Methods:This case-control study was conducted on 458 mothers in two groups of unsuccessful breastfeeding (case) and successful breastfeeding (control) attending Kashan province health clinics. In this study, the GHQ questionnaire and clinical interview were employed to collect data. The data were statistically analyzed using Chi-square and Fisher’s exact tests.Results:It was found that mothers of the case group had a greater susceptibility to depression than those of the control group, that is, breastfeeding status was directly associated with susceptibility to depression (P = 0.001, OR = 5.48). Furthermore, there was a significant association between basic characteristics such as maternal occupational status (P = 0.04) or their educations (P = 0.006) with breastfeeding. Besides, clinical interview revealed that mixed depression and anxiety disorder was the most prevalent type of psychological disorder in the case group.Conclusions:Screening depression during pregnancy and postpartum period appeared to be necessary and it should be incorporated into prenatal and postnatal care due to its influence on mothers’ successful breastfeeding.
The results of this study suggest that patients could be ambulated three to four hours after sheath removal following percutaneous coronary interventions and early ambulation dose does not increase the risk of vascular complications, but it moderates back pain occurrence.
Highlights
Early postpartum is a crucial time for mothers whit preeclampsia concomitant with COVID-19 symptoms. It may lead to severe and sometimes fatal consequences.
We report of the first maternal death in Balouchestan of Iran due to complicated delivery with preeclampsia concomitant with COVID-19 in early postpartum.
Mothers with features of preeclampsia may be at greater risk to develop severe form of COVID-19 and can rapidly progressed to respiratory distress and coagulopathy state in early postpartum.
Preeclampsia features could be present in some pregnancies with a severe course of COVID-19.
Severe COVID-19 can lead to a hypercoagulable state as in other sepsis. Also it has even a greater risk during pregnancy and more even after delivery due to physiological changes of pregnancy.
COVID-19 and preeclampsia can have similar clinical manifestations and laboratory changes. Therefore, the differential diagnosis demands a careful assessment in pregnant women presenting with preeclampsia and HELLP syndrome features.
Detailed assessments are essential for all preeclamptic and high BP mothers during COVID-19 pandemic.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.